Volume 91, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Madura foot is a chronic infection caused by fungus and/or bacteria. Traditionally, treatment has been surgical debridement or amputation. Non-invasive management with long-term antimicrobials alone has been reported as successful. We report a case of Madura foot in a Somali refugee successfully managed with oral posaconazole and ciprofloxacin.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Hershkovitz I, Speirs M, Katznelson A, Arensburg B, , 1992. Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. Am J Phys Anthropol 88: 2326.[Crossref] [Google Scholar]
  2. Kaufman MH, , 2007. Sir George Ballingall (1786–1855): Regius Professor of Military Surgery in the University of Edinburgh. J Med Biogr 15: 7581.[Crossref] [Google Scholar]
  3. Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A, , 2007. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20: 146151.[Crossref] [Google Scholar]
  4. McGinnis MR, , 1996. Mycetoma. Dermatol Clin 14: 97104.[Crossref] [Google Scholar]
  5. van de Sande WW, , 2013. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2550.[Crossref] [Google Scholar]
  6. Ameen M, Arenas R, , 2009. Developments in the management of mycetomas. Clin Exp Dermatol 34: 17.[Crossref] [Google Scholar]
  7. Parker L, Singh D, Biz C, , 2009. The dot-in-circle sign in Madura foot. J Foot Ankle Surg 48: 690.e15.[Crossref] [Google Scholar]
  8. Mahgoub ES, , 1976. Medical management of mycetoma. Bull World Health Organ 54: 303310. [Google Scholar]
  9. Fahal AH, Shaheen S, Jones DH, , 2014. The orthopedic aspects of mycetoma. Bone Joint J 96-B: 420425.[Crossref] [Google Scholar]
  10. Garnica M, Nucci M, Queiroz-Telles F, , 2009. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 22: 559563.[Crossref] [Google Scholar]
  11. Keating GM, , 2005. Posaconazole. Drugs 65: 15531567, discussion 68–69.[Crossref] [Google Scholar]
  12. Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, , 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339346.[Crossref] [Google Scholar]
  13. Zoller E, Valente C, Baker K, Klepser ME, , 2010. Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug Des Devel Ther 4: 299311. [Google Scholar]
  14. Jain V, Makwana GE, Bahri N, The MK, , 2012. “Dot-in-Circle” sign on MRI in maduramycosis: a characteristic finding. J Clin Imaging Sci. 2: 66.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 30 May 2014
  • Accepted : 29 Jun 2014
  • Published online : 03 Dec 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error